I E Smith

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern et al. · JNCI Journal of the National Cancer Institute · 2011 · 2K citations · Full text

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.

Jacqueline C. Newby, Stephen Johnston, I E Smith et al. · PubMed · 1997 · 192 citations

Breast Oncology, Receptor Pretreatment, Immunology +16

Activity of docetaxel (Taxotere) in small cell lung cancer

J F Smyth, I E Smith, C. Sessa et al. · European Journal of Cancer · 1994 · 138 citations

Medicine, Pharmacology, Anti-cancer Agent +3

Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer.

Timothy Iveson, I E Smith, Julie Ahern et al. · PubMed · 1993 · 130 citations

Breast Oncology, Cgs 20267, Gynecology +20